TNFAIP6 (TNF Alpha Induced Protein 6), also known as TSG-6 (Tumor Necrosis Factor-Stimulated Gene 6 protein), is a secreted glycoprotein that plays crucial roles in cell adhesion, inflammatory responses, and extracellular matrix organization [1]. Discovered as a TNF-α-inducible gene in fibroblasts, TSG-6 has emerged as an important mediator of inflammation and tissue remodeling in various physiological and pathological contexts.
The TNFAIP6 gene encodes a 354-amino acid precursor protein that undergoes proteolytic processing to generate a mature secreted protein of approximately 35 kDa [2]. This protein is characterized by its unique ability to bind hyaluronan (HA) and other glycosaminoglycans, making it a key regulator of the extracellular matrix and cell-matrix interactions.
Located on chromosome 2p23.3, the TNFAIP6 gene is expressed in a variety of tissues and cell types, with particularly high expression in inflamed tissues, activated leukocytes, and stromal cells [3]. In the central nervous system, TNFAIP6/TSG-6 is expressed in astrocytes, microglia, and neurons, where it modulates neuroinflammatory responses and contributes to neural repair processes.
| TNF Alpha Induced Protein 6 | |
|---|---|
| Gene Symbol | TNFAIP6 |
| Full Name | TNF alpha induced protein 6 (TSG-6) |
| Chromosome | 2p23.3 |
| NCBI Gene ID | [7132](https://www.ncbi.nlm.nih.gov/gene/7132) |
| OMIM | 191163 |
| Ensembl ID | ENSG00000123607 |
| UniProt ID | [P20742](https://www.uniprot.org/uniprot/P20742) |
| Protein Class | Secreted glycoprotein, Hyaluronan-binding protein |
| Aliases | TSG-6, Hyaluronan-binding protein 2 |
| Associated Diseases | Alzheimer's Disease, Neuroinflammation, Multiple Sclerosis, Brain injury |
The TNFAIP6 gene spans approximately 6 kb on chromosome 2p23.3 and consists of 7 exons [4]. The gene promoter contains multiple responsive elements, including:
TSG-6 possesses a modular architecture with distinct functional domains:
N-terminus (1-80 aa) Link module (81-250 aa) C-terminus (251-354 aa)
┌────────────────────┐ ┌──────────────────┐ ┌────────────────────┐
│ Signal peptide │ │ Link module │ │ CUB domain │
│ (1-23 aa) │ │ (hyaluronan │ │ (complement │
│ │ │ binding) │ │ proteinases) │
│ Propeptide │ │ │ │ │
│ (24-80 aa) │ │ Serum albumin │ │ Protein-protein │
│ │ │ motif │ │ interactions │
└────────────────────┘ └──────────────────┘ └────────────────────┘
Signal Peptide — The N-terminal 23-amino acid signal peptide directs TSG-6 to the secretory pathway. This allows the protein to be secreted and act extracellularly.
Link Module — The central Link module (amino acids 81-250) is the key functional domain responsible for hyaluronan binding [5]. This domain shares homology with the hyaluronan-binding regions of other proteins like CD44 and aggrecan.
CUB Domain — The C-terminal domain (amino acids 251-354) is structurally related to complement proteins (CUB domain) and mediates protein-protein interactions.
TSG-6 undergoes specific post-translational modifications [6]:
TSG-6's primary function is binding hyaluronan, a major component of the extracellular matrix [7]:
This hyaluronan-binding function is critical for tissue remodeling and repair processes.
TSG-6 exerts potent anti-inflammatory effects through multiple mechanisms [8]:
These anti-inflammatory properties make TSG-6 important in both acute and chronic inflammatory conditions.
TSG-6 modulates cell-cell and cell-matrix adhesion [9]:
The balance between promoting and inhibiting cell adhesion depends on the cellular context.
TSG-6 affects various immune cell functions [10]:
TNFAIP6 exhibits inducible expression across multiple tissues [11]:
| Tissue | Expression Level | Regulation |
|---|---|---|
| Brain | Moderate | Strongly inducible |
| Lung | High | Inducible by inflammation |
| Heart | Low-Moderate | Constitutive + inducible |
| Skin | High | Inducible |
| Joint tissue | Very high | Inflammatory |
| Eye | Moderate | Inducible |
Within the central nervous system, TSG-6 expression is dynamically regulated [12]:
Astrocytes — Primary source of TSG-6 in the brain. Reactive astrocytes upregulate TNFAIP6 in response to inflammatory stimuli.
Neurons — Lower expression, but neurons can produce TSG-6 under certain conditions.
Microglia — Activated microglia express TSG-6, contributing to anti-inflammatory responses.
Endothelial cells — Vascular endothelial cells produce TSG-6, affecting blood-brain barrier function.
TSG-6 expression is tightly controlled at multiple levels [13]:
TSG-6 dysregulation contributes to Alzheimer's disease pathogenesis [14]:
Neuroinflammation:
Therapeutic Implications:
In demyelinating diseases [15]:
TSG-6 plays protective roles in acute brain injury [16]:
Neuroprotection:
Therapeutic Implications:
In chronic neuroinflammatory conditions [17]:
TSG-6 interacts with multiple protein partners [18]:
Direct Partners:
Functional Partners:
TSG-6 interfaces with multiple signaling cascades [19]:
Tnfaip6-deficient mice have provided important insights [20]:
Overexpression studies show [21]:
TSG-6 administration studies demonstrate [22]:
TNFAIP6 genetic variants have been associated with [23]:
| Variant Type | Effect | Disease Association |
|---|---|---|
| Missense | Altered HA binding | Variable |
| Promoter variants | Altered expression | Inflammatory disease |
| 3' UTR variants | Altered mRNA stability | Modified risk |
Several approaches to modulate TSG-6 for therapeutic benefit are under investigation [24]:
| Approach | Mechanism | Status |
|---|---|---|
| Recombinant protein | Deliver TSG-6 | Preclinical |
| Gene therapy | Deliver TNFAIP6 gene | Early trials |
| Small molecules | Enhance expression | Discovery |
| Cell therapy | TSG-6-modified cells | Early research |
Therapeutic targeting of TSG-6 faces significant challenges [25]:
TSG-6 as a biomarker [26]:
| Feature | TNFAIP6 (TSG-6) | TNFAIP3 (A20) | TNFAIP1 (BAP1) |
|---|---|---|---|
| Function | HA binding, anti-inflammatory | DUB + E3 ligase | DUB + tumor suppressor |
| Localization | Extracellular/secreted | Cytoplasmic | Nuclear |
| Primary role | Matrix remodeling | Inflammation | DNA damage |
| Expression | Inducible | Inducible | Constitutive |
TSG-6 expression analysis may be useful for [27]:
No current clinical trials specifically targeting TNFAIP6 in neurodegeneration, but:
TNFAIP6/TSG-6 represents a unique anti-inflammatory protein with important roles in extracellular matrix organization and neuroinflammation control. Its ability to bind hyaluronan and modulate inflammatory responses makes it relevant to neurodegenerative diseases and brain injury. Understanding and targeting TSG-6 offers therapeutic opportunities for conditions characterized by excessive neuroinflammation.